Severe fingolimod rebound syndrome after switching to cladribine treatment

被引：10

作者：

Coss-Rovirosa, Fernanda ^{[1
]}

Salado-Burbano, Jorge ^{[1
]}

Casallas-Vanegas, Adriana ^{[2
]}

Elizabeth Caire-Herrera, Laura ^{[3
]}

Gomez-Figueroa, Enrique ^{[1
,2
]}

Flores-Rivera, Jose ^{[1
,2
]}

机构：

[1] Amer British Cowdray Med Ctr, Mexico City, DF, Mexico

[2] Inst Nacl Neurol & Neurocirug, Mexico City, DF, Mexico

[3] Hosp Psiquiatr Infanta Juan N Navarro, Mexico City, DF, Mexico

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 40卷

关键词：

Fingolimod; Rebound; Cladribine; Multiple sclerosis; MULTIPLE-SCLEROSIS; DISEASE REACTIVATION;

D O I：

10.1016/j.msard.2020.101938

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We present the clinical and imaging characteristics of a patient whom presented with rebound syndrome after switching from fingolimod to cladribine treatment due to hematologic toxicity. Previous imaging studies had shown a non-aggressive phenotype of the disease, however multiple active tumefactive lesions became evident after beginning treatment with cladribine. The patient responded well to plasmapheresis.

引用

页数：3

共 50 条

[1] Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis
Nygaard, Gro Owren
Torgauten, Hilde
Skattebol, Lars
Hogestol, Einar August
Sowa, Piotr
Myhr, Kjell-Morten
Torkildsen, Oivind
Celius, Elisabeth Gulowsen
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
[2] Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis
Gunduz, Tuncay
Kurtuncu, Murat
Eraksoy, Mefkure
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 11 : 1 - 3
[3] Rebound Syndrome In Patients With Multiple Sclerosis After Stopping Fingolimod Treatment
Diaz-Perez, C.
Meca-Lallana, V.
Aguirre, C.
Del Rio, B.
Carabajal, E.
Martin Villalba, R.
Vivancos, J.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 101 - 102
[4] Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment
Hatcher, Stacy Ellen
Waubant, Emmanuelle
Nourbakhsh, Bardia
Crabtree-Hartman, Elizabeth
Graves, Jennifer S.
[J]. JAMA NEUROLOGY, 2016, 73 (07) : 790 - 794
[5] Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation
Andrade, Chittaranjan
[J]. JAMA NEUROLOGY, 2016, 73 (11) : 1375 - 1376
[6] Rebound syndrome in MS patients after stopping fingolimod
[J]. Reactions Weekly, 2016, 1602 (1) : 10 - 10
[7] Rebound disease activity after cessation of fingolimod treatment
Gunduz, T.
Ismailov, R.
Kurtuncu, M.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 552 - 552
[8] Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation Reply
Hatcher, Stacy Ellen
Waubant, Emmanuelle
Graves, Jennifer S.
[J]. JAMA NEUROLOGY, 2016, 73 (11) : 1376 - 1376
[9] Rebound Syndrome in Multiple Sclerosis Patients After Cessation of Fingolimod
Hatcher, Stacy
Waubant, Emmanuelle
Nourbakhsh, Bardia
Crabtree-Hartman, Elizabeth
Graves, Jennifer
[J]. NEUROLOGY, 2016, 86
[10] Rebound syndrome in multiple sclerosis patients after cessation of fingolimod
Hatcher, Stacy E.
Waubant, Emmanuelle
Nourbakhsh, Bardia
Crabtree-Hartmann, Elizabeth
Graves, Jennifer S.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 25 - 25

← 1 2 3 4 5 →